ASIT Biotech

ASIT Biotech S.A.
Stock Exchange Euronext Brussels
EPS
EUR0.86
Market Cap
EUR23.21 M
Shares Outstanding
20.48 M
Public Float
11.39 M

Profile

Address
Avenue Ariane 5
Woluwe-Saint-Lambert BU 1200
Belgium
Employees -
Website http://www.asitbiotech.com
Updated 07/08/2019
ASIT BioTech SA operates as clinical stage biopharmaceutical company. It focuses on the development and future commercialization of immunotherapy products for the treatment of allergies, based on its ASIT technology platform. The company was founded by Thierry Legon in May 1997 and is headquartered in Brussels, Belgium.

Financials

View All

Gerd Zettlmeissl
Chairman
Everard van der Straten
Chief Financial Officer & Executive Director